Stay updated on Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.

Latest updates to the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed reference to v3.1.0.SummaryDifference1%
- Check20 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; Back to Top removed. No substantive changes to core content or key data.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check48 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new facility name and location details, as well as important safety studies related to the drug guselkumab. Several previous location entries have been removed, indicating a potential focus shift in the content.SummaryDifference3%
- Check63 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Guselkumab in Active PsA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Active PsA: Efficacy & Safety Clinical Trial page.